The 20 Best Metabolic Syndrome Doctors Near Me in Fairfax, VA

Zobair Younossi practices practicing medicine in Falls Church, Virginia. Dr. Younossi is rated as an Elite provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Hepatitis C, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Heart Transplant.

Nehal Mehta is a Cardiologist practicing medicine in Washington,, Washington, D.c.. Dr. Mehta is rated as an Elite provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Atherosclerosis, Metabolic Syndrome, Coronary Heart Disease, Abdominal Obesity Metabolic Syndrome, and Vitrectomy.

Young Park is a Cardiologist practicing medicine in Fairfax, Virginia. Dr. Park is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Atherosclerosis, Angina, and Coronary Heart Disease.

Syed Shahab is an Interventional Cardiologist practicing medicine in Fairfax, Virginia. Dr. Shahab is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Congenital Mitral Malformation, Aortic Regurgitation, Angina, and Rheumatic Fever.

System Associate Director for Interventional Cardiology Executive Director of the Cardiac Catheterization Laboratories for Inova Co-Director of Complex Coronary Therapeutic Program Dr. Behnam N. Tehrani also serves as an assistant clinical professor of medicine at both George Washington University and the University of Virginia. He is involved in clinical trials and registries pertaining to complex coronary interventions, renal denervation, cardiogenic shock and pulmonary embolism. In line with Inova’s mission and values, Dr. Tehrani has dedicated his career to the development of team-based systems of care – bringing together specialists to collaborate on patient care, using innovative technologies coupled with research and a lifelong commitment to education and learning. He played a key role in creating Inova’s cardiogenic shock team, which has become a national leader in improving survival rates for this life-threatening condition. He also co-leads the team that performs advanced, technically complex catheter-based procedures for patients with severe coronary artery disease who are at elevated risk and often have limited treatment options. This includes procedures for chronic total occlusion, a complete blockage in the coronary arteries. Dr. Tehrani is also part of the team that introduced renal denervation services for treating resistant hypertension, as well as the rapid-response team for diagnosing and treating pulmonary embolism and the team that treats chronic thromboembolic pulmonary hypertension. Recognized nationally for his leadership, Dr. Tehrani serves on committees for both the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions. He has co-authored more than 100 peer-reviewed publications, abstracts and book chapters, with his work published in top medical journals including Journal of the American College of Cardiology (JACC), JACC: Heart Failure, JACC: Cardiovascular Interventions, JAMA Cardiology, Circulation: Heart Failure, and Journal of the Society for Cardiovascular Angiography and Interventions. He also contributes as a peer reviewer for Journal of the American College of Cardiology, Circulation, European Heart Journal, American Heart Journal, and Catheterization and Cardiovascular Interventions. Dr. Tehrani is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Cardiogenic Shock, Heart Attack, Pulmonary Hypertension, Percutaneous Coronary Intervention (PCI), and Lithotripsy.

Dr. Kevin Rogan is a specialty care physician board certified in cardiovascular disease, nuclear cardiology, interventional cardiology, and internal medicine. He joined Inova with more than 32 years of clinical experience. He has a special interest in management of coronary artery disease and congestive heart failure. Dr. Rogan serves as the Director for Non-Invasive Cardiology at Inova Fairfax Hospital, supervising the performance of echocardiography and stress testing. Dr. Rogan became interested in cardiology because of the exciting progress made in treatments for heart attacks and congestive heart failure. His goal is to help his patients continue normal active lifestyles. A native of Boston, MA, Dr. Rogan moved to the DC area while on active duty in the United States Army. He lives with his wife and three children. In his spare time he likes to run, bike, scuba dive, and avidly follow the Boston Red Sox. Dr. Rogan is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Angina, Atherosclerosis, and Coronary Heart Disease.

Paul Dilorenzo is a Cardiologist and an Internal Medicine provider practicing medicine in Fairfax, Virginia. Dr. Dilorenzo is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses X-Linked Cardiac Valvular Dysplasia, Cardiac Diverticulum, Aortic Valve Stenosis, Atrial Fibrillation, and Pacemaker Implantation.

Dr. Michael Escano is a specialty care physician board certified in cardiovascular disease. He joined Inova in 2025 and has been practicing since 1999. Prior to joining Inova, Dr. Escano was a noninvasive cardiologist at UVA – Prince William Cardiology in Manassas, VA. Dr. Escano is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Long QT Syndrome 1, Long QT Syndrome, Timothy Syndrome, and Long QT Syndrome 5.

President, Inova Medicine Service Line Schar Chair, Inova Schar Heart and Vascular Director Emeritus, Interventional Cardiology, Inova Professor of Medicine, Duke University School of Medicine Wayne Batchelor, MD, MHS, MBA, is President of the Medicine Service Line. He joined Inova in 2019 with more than two decades of executive leadership in academic medicine, private practice, clinical research, and education. He is Professor of Medicine (adj.), Duke University, Chair of the American College of Cardiology (ACC) Interventional Sectional Leadership Council, and Vice-Chair of the STS/ACC Transcatheter Valve Therapy (TVT) Registry. He has previously served as an academic cardiologist at the University of Toronto, President of Southern Medical Group, PA in Tallahassee, Florida, Board Member of Tallahassee Memorial Healthcare, and Co-Founder/President of the Tallahassee Research Institute (TRI). He is internationally recognized for his clinical and research expertise in interventional cardiology, clinical trials, outcomes research, regulatory science, and healthcare disparities in medicine. Fostering multidisciplinary collaborations within and between service lines, Dr. Batchelor has successfully built innovative clinical programs and improved patient outcomes within both private practice and academic medical settings. He has published more than 200 peer-reviewed abstracts and manuscripts, multiple book chapters, served on numerous clinical trial steering committees and as National Principal Investigator (PI) on landmark clinical trials in cardiovascular medicine. He is a special consultant to the U.S. Food and Drug Administration (FDA) within the Cardiovascular Devices Branch, has served on the editorial boards for Circulation, the Journal of the Society of Cardiovascular Angiography and Interventions, and Cardiovascular Revascularization Medicine and is a Senior Advisor and frequent Guest Editor for the Journal of the American College of Cardiology. Dr. Batchelor earned his bachelor of science and medical degree from Queens University in Kingston, Ontario, Canada, a master's degree in clinical research from Duke University, and an Executive MBA from New York University. Dr. Batchelor is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Cardiogenic Shock, Mitral Valve Regurgitation, Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Dr. Ahsan Jafir is a specialty care physician board certified in interventional cardiology and cardiovascular disease. He joined Inova in 2025 and has been practicing since 2004. Prior to joining Inova, Dr. Jafir was an interventional cardiologist at Novant Health UVA Health System Prince William Cardiology in Manassas, VA. Dr. Jafir is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Heart Attack, Necrosis, Heart Failure with Preserved Ejection Fraction (HFpEF), Familial Ventricular Tachycardia, and Pacemaker Implantation.

Garima Sharma is a Cardiologist practicing medicine in Fairfax, Virginia. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Heart Attack, Peripartum Cardiomyopathy, Apoplexy, and Cardiomyopathy.

Ana Barac, MD, PhD, FACC, FAHA Dr. Ana Barac is the Inova Schar Cancer and Inova Schar Heart and Vascular's D'Aniello Chair, Cardio-Oncology. Dr. Barac also serves as the Medical Director of the Cardio-Oncology Program. This leadership position represents a substantial enhancement to Inova's Cardio-Oncology Program, made possible through the generous support of Dan and Gayle D'Aniello. The program will build comprehensive cardiovascular care for patients across the cancer treatment continuum, from diagnosis through survivorship. Prior to joining Inova, Dr. Barac was the Director of Medstar Heart and Vascular Institute's Cardio-Oncology Program. She is a Professor of Medicine at Georgetown University, was the founding Chair of the American College of Cardiology's (ACC) Cardio-Oncology Council and serves as Co-Director of the ACC's Annual Live Course on Advancing Cardiovascular Care in Oncology Patients. She has chaired Heart House Roundtables at ACC's headquarters on cardiovascular disease and cancer treatment and has been a member of writing committees for multidisciplinary professional society guidelines and consensus documents addressing cardiovascular concerns in patients with cancer. Dr. Barac serves on the editorial board of the Journal of the American College of Cardiology (JACC), is a senior advisor for JACC: Cardio-Oncology and is an editorial consultant for JACC: Heart Failure. Dr. Barac's clinical and research areas of interest focus on advanced cardiovascular imaging, the applications of cardiac magnetic resonance and echocardiography in investigations of cardiovascular effects of cancer therapies. Dr. Barac is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Bidirectional Tachycardia, Catecholaminergic Polymorphic Ventricular Tachycardia, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

Mubarik Khan is a primary care provider, practicing in Internal Medicine in Fairfax, Virginia. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Tracheitis, Empyema, Infant Hyperglycemia, and Sinusitis.

Dr. Sachin Gandhi is a specialty care physician board certified in internal medicine, cardiovascular disease, echocardiography and nuclear cardiology. He joined Inova in 2023 and has been practicing since 2005. Prior to joining Inova, Dr. Gandhi worked as a staff cardiologist and as Director of Satellite Cardiac Services at Cleveland Clinic Akron General in Akron, OH. Dr. Gandhi is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Transient Ischemic Attack (TIA), Pulmonary Edema, Heart Attack, and Heart Failure.

Dr. Jared A. Spitz is a specialty care physician board certified in cardiovascular disease at Inova. He joined Inova in 2022 and has been practicing since 2016. Prior to joining Inova, Dr. Spitz was a clinical fellow in cardiovascular disease at New York Presbyterian Hospital – Weill Cornell Medical Center in New York and a resident in internal medicine at Johns Hopkins Hospital in Baltimore. In addition to general cardiology, Dr. Spitz has had advanced training advanced lipid disorders and has a particular clinical focus on advanced lipid disorders, complex cardiovascular prevention and cardiometabolic health. He has worked at Inova to build an advanced lipid clinic and has helped to create a comprehensive cardiometabolic prevention program. He sees patients with genetic and hard-to-treat cholesterol conditions as well as those with significant risk for heart disease who need comprehensive management of all their risk factors. In addition to his clinical practice, Dr. Spitz is actively engaged in clinical trials, in particular those focusing on managing cholesterol conditions as well as those focusing on cardiometabolic and preventive strategies. He also researches and publishes on cholesterol and metabolic-health-related cardiac conditions. Dr. Spitz seeks to provide all patients with comprehensive cardiac care, utilize cutting-edge preventive therapies, and provide patients access to the newest medications and available clinical trials. Dr. Spitz is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses High Cholesterol, Atherosclerosis, Sinus of Valsalva Aneurysm, and Inappropriate Sinus Tachycardia (IST).

Dr. Tina Slottow is a specialty care physician board certified in cardiovascular disease, interventional cardiology, echocardiography, and nuclear cardiology. She joined Inova with over 12 years of clinical experience and has a special interest in informatics and leveraging AI technologies to enhance cardiovascular care. Dr. Slottow became interested in cardiology to educate patients about cardiovascular health and preventing cardiovascular disease. She was also fascinated by the numerous well-studied and effective therapies available. Her goal is to help patients understand how their hearts function, how to modify risk factors and how to live with, not suffer from, cardiovascular disease. She wants her patients to be as active and unlimited as possible. A native of Pittsburgh, PA, Dr. Slottow resides in Falls Church, VA with her husband and sons. In her spare time, she likes to travel and spend time with her family. Dr. Slottow is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. Her clinical expertise encompasses Atrial Fibrillation, Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiomyopathy, and Sengers Syndrome.

Nicholas Balaji, MD, is a specialty care cardiologist board certified in interventional cardiology, nuclear cardiology, cardiovascular disease, and internal medicine. He joined Inova Medical Group in 2013. He has a special interest in the management of coronary artery disease and radial artery catheterization for diagnostic and therapeutic coronary interventions. Dr. Balaji became interested in cardiology because of the continuing technological advances within the field. His goal is to help promote cardiovascular health, and to develop a collaborative treatment plan to prevent future illness, manage chronic conditions, and improve quality of life for patients and their families. A native of Rochester, New York, Dr. Balaji currently resides in Alexandria, VA with his wife and two young children. In his spare time he likes to spend time with his family, jog, and purse his interest in photography. Dr. Balaji is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Heart Attack, Apoplexy, Angina, and Atrial Fibrillation.

Video: Heart disease in women: the differences you need to know (Sept. 30, 2025) What You Need to Know About Cardiovascular Health During Pregnancy (February 2022) Video: Inova Health Talk: Women's Heart Health (February 2020). Dr. Pinell is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Carotid Artery Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Arterial Embolism, and Chagas Disease.

Khalid Abousy is a Cardiologist and an Interventional Cardiologist practicing medicine in Annandale, Virginia. Dr. Abousy is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Angina, Heart Attack, Coronary Heart Disease, Atherosclerosis, and Bone Marrow Aspiration.

Stuart Sheifer is a Cardiologist practicing medicine in Vienna, Virginia. Dr. Sheifer is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pediatric Myocarditis, Hypertensive Heart Disease, Atherosclerosis, and Coronary Heart Disease.